Castlight Health Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Castlight Health in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Castlight Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSLT, but not buy additional shares or sell existing shares.
View analyst ratings for Castlight Health or view top-rated stocks.

Wall Street analysts have given Castlight Health a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Castlight Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Castlight Health saw a increase in short interest in January. As of January 15th, there was short interest totaling 1,880,000 shares, an increase of 16.8% from the December 31st total of 1,610,000 shares. Based on an average trading volume of 704,500 shares, the short-interest ratio is currently 2.7 days.
View Castlight Health's Short Interest.

Castlight Health is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Castlight Health.

Castlight Health, Inc. (NYSE:CSLT) posted its quarterly earnings data on Tuesday, February, 23rd. The software maker reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.06. Castlight Health had a negative net margin of 49.79% and a negative trailing twelve-month return on equity of 12.18%.
View Castlight Health's earnings history.

Castlight Health's stock was trading at $0.83 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CSLT shares have increased by 118.1% and is now trading at $1.81.
View which stocks have been most impacted by COVID-19.

Castlight Health issued an update on its FY 2021 After-Hours earnings guidance on Tuesday, February, 23rd. The company provided earnings per share (EPS) guidance of -0.06--0.02 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.00. The company issued revenue guidance of $130-135 million, compared to the consensus revenue estimate of $138.17 million.

2 analysts have issued 12-month price objectives for Castlight Health's shares. Their forecasts range from $0.75 to $2.00. On average, they anticipate Castlight Health's share price to reach $1.38 in the next twelve months. This suggests that the stock has a possible downside of 24.0%.
View analysts' price targets for Castlight Health or view top-rated stocks among Wall Street analysts.

36 employees have rated Castlight Health CEO Maeve OMeara on Glassdoor.com. Maeve OMeara has an approval rating of 79% among Castlight Health's employees.

Some companies that are related to Castlight Health include Veritone (VERI), Tucows (TCX), Cars.com (CARS), Brightcove (BCOV), Sohu.com (SOHU), CC Neuberger Principal Holdings I (PCPL), Kaleyra (KLR), GTY Technology (GTYH), Liberty TripAdvisor (LTRPA), ZIX (ZIXI), BlueCity (BLCT), IBEX (IBEX), Ooma (OOMA), NantHealth (NH) and Scienjoy (SJ).
View all of CSLT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Castlight Health investors own include Zosano Pharma (ZSAN), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), ADMA Biologics (ADMA), Chesapeake Energy (CHKAQ), Hallador Energy (HNRG), Miragen Therapeutics (MGEN), Novan (NOVN), OrganiGram (OGI) and Sorrento Therapeutics (SRNE).

Castlight Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CSLT."

Castlight Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Raging Capital Management LLC (6.45%), Whetstone Capital Advisors LLC (3.47%), BlackRock Inc. (1.98%), Renaissance Technologies LLC (1.93%), Royce & Associates LP (1.67%) and Perkins Capital Management Inc. (0.78%). Company insiders that own Castlight Health stock include John C Doyle, Maeve O'meara, Mangini Siobhan Nolan, MP Eric Chan, Neeraj Gupta, Seth B Cohen, William Bondurant and Zant Kenny Van.
View institutional ownership trends for Castlight Health.

CSLT stock was sold by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC, BlackRock Inc., Raging Capital Management LLC, Dimensional Fund Advisors LP, Hsbc Holdings PLC, Wells Fargo & Company MN, Perkins Capital Management Inc., and Russell Investments Group Ltd.. Company insiders that have sold Castlight Health company stock in the last year include Maeve O'meara, MP Eric Chan, Seth B Cohen, and William Bondurant.
View insider buying and selling activity for Castlight Health or view top insider-selling stocks.

CSLT stock was bought by a variety of institutional investors in the last quarter, including ExodusPoint Capital Management LP, Renaissance Technologies LLC, New York Life Investments Alternatives, Whetstone Capital Advisors LLC, Royce & Associates LP, Brookside Equity Partners LLC, Assenagon Asset Management S.A., and Virtu Financial LLC. Company insiders that have bought Castlight Health stock in the last two years include Maeve O'meara, William Bondurant, and Zant Kenny Van.
View insider buying and selling activity for Castlight Health or or view top insider-buying stocks.

Shares of CSLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CSLT stock can currently be purchased for approximately $1.81.

Castlight Health has a market capitalization of $278.34 million and generates $143.31 million in revenue each year. The software maker earns $-40,000,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis.

Castlight Health employs 463 workers across the globe.

The official website for Castlight Health is www.castlighthealth.com.

Castlight Health is headquartered at 150 SPEAR STREET SUITE 400, SAN FRANCISCO CA, 94105.

Castlight Health's mailing address is 150 SPEAR STREET SUITE 400, SAN FRANCISCO CA, 94105. The software maker can be reached via phone at 415-829-1400 or via email at [email protected]